Andrew is an experienced European and Chartered UK Patent Attorney. His career to date has focused largely on drafting and prosecution work for a wide range of clients, including multinational companies, universities and high tech spin out companies.
As well as having extensive experience in drafting, filing and prosecuting UK, European and international (PCT) patent applications, Andrew has considerable experience in prosecuting patent applications for his clients in various countries around the world including in particular the US, China, Japan and Korea. Andrew is also experienced in European patent oppositions, and has appeared before the EPO Board of Appeal.
Andrew is also experienced in performing due diligence for investors, performing IP audits, providing patent filing strategy advice, providing patentability opinions, freedom to operate analysis and providing opinions on patent infringement and validity.
Having completed an undergraduate masters degree in electronic and electrical engineering and a PhD in tunable diode laser spectroscopy, Andrew has a broad technical base in electronics, photonics and physics. Andrew also has significant patent experience in computer software, wireless communications, human machine interfaces, low power microprocessors, mobile device positioning, MEMS, image sensors, image processing, acoustic wave attenuators, hydraulic pumps and motors, valves, medical devices and aerospace technologies. Andrew also has a growing interest in AI and Machine Learning.
Electronic and Electrical Engineering (with distinction) from the University of Strathclyde
Electronic and Electrical Engineering from the University of Strathclyde
Listed in the IAM Patent 1000: The World’s Leading Patent Professionals for several years
Andrew plays a leading role in shaping HGF’s training offering for trainee patent attorneys, including exam mentoring and tutoring for the UK and EQE final patent exams.
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.